“investing” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Federation Bio Bags $50M to Engineer New Approach to Microbiome Drugs 10/06/20 Boston
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins 09/29/20 Europe
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Generate Bio Aims to Reveal Nature’s Protein Secrets, Create New Drugs 09/10/20 Boston
AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase 09/04/20 National
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally 09/03/20 Boston
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections 08/12/20 Europe
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology 08/05/20 Boston
Omega Therapeutics Lands $85M to Tap Into “Control Room” of Biology 07/29/20 Boston
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Forge Bio’s Combo Model for Gene Therapies Attracts $40M in Funding 07/21/20 National
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s 07/01/20 Boston
AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis 06/24/20 National
Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx 06/22/20 San Francisco
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs 06/18/20 San Diego
Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies 06/17/20 San Francisco
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain” 06/09/20 Boston
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Page 1 of 25 next page »